Abstract:Objective To investigate germline mutation of breast cancer susceptibility genes BRCA1/2,TP53 and PTEN in Chinese breast cancer patients. Methods All of128 female breast cancer patients in Peking University People′s Hospital from January 2016 to August 2018 were selected as objects. Among them,44 cases were sporadic breast cancer and 84 werebreast cancer patients with genetic high risks. Germline mutations of BRCA1,BRCA2,TP53 and PTENwere detected by NGS.χ2 test was used to analyze the difference of pathogenic mutation rates between sporadic breast cancer group and breast cancer with high genetic risks.Groups were divided according to the clinical features of the patients(family history, triple-negative breast cancer,age and bilateral breast cancer).Among them,there were 42 cases with family history of breast cancer,34 cases of triple-negative breast cancer,33 cases of early-onset breast cancer and 7 cases of bilateral breast cancer. Fisher′s exact probability test compared the relationship between pathogenic mutations of BRCA1/2 gene and clinical characteristics of breast cancer patients with hereditary risk factors. Results In 128 cases of breast cancer,30 germline mutations of BRCA1/2 were detected, including 13 pathogenic mutations and 3 newly discovered mutations(BRCA1:c. 4760C>G,BRCA2:c. 44134414del and BRCA2:c. 64826485del). The new mutations may be unique mutations of Chinese population. There were 3 cases of TP53 mutations,including 1 pathogenic mutation. All of the 3 mutations were found in early-onset breast cancer. Germline mutation of T53 has important detection significance for early-onset hereditary breast cancer. There were 5 cases of PTEN mutations,including 3 pathogenic mutations. Among 84 breast cancer patients with genetic high risks,the carry mutation rate was 40.5％(34/84)and the pathogenic mutation rate was 15.4(13/84). Among 44 sporadic cases,the carry mutation rate was 9％(4/44). The pathogenic mutation rate was 6.8％(3/44). Breast cancer susceptibility genes were carried at a higher rate in breast cancer patients with genetic high risks(P<0.001). BRCA1/2 mutations did not show statistical differences among groups of breast cancer patients with hereditary high risk factors . Conclusion Germline mutation detection of breast cancer susceptibility genes by next-generation sequencing is of great significance in breast cancer risk prediction and prognosis evaluation.

Study on P-gp gene mutation and molecular mechanism of multi-drug resistance of breast cancer

Relationship between P-gp gene mutation and multi-drug resistance of breast cancer

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

Relationship Between the P53 Functional Status of Human Tumor Cell Lines and Their Chemosensitivities to Different Anticancer Drug

Relation Between Mutant P53 and Multidrug Resistance in Gastric Cancer

Impact of drug resistance gene on breast cancer chemotherapy

Influence of Neoadjuvant Chemotherapy on the Expression of Drug Resistance Genes in Breast Carcinoma

STUDY ON THE METHYLATION OF P16 GENE AND GENETIC POLYMORPHISM OF GSTM1 GENE RELATED WITH SUSCEPTIBILITY TO NON-SMALL CELL LUNG CANCER

Effect of Multidrug-Resistant-proteins in Neoadjuvant Chemotherapy in Patients with Breast Cancer

Detection of multi-pathway genes and analysis of gene mutations in breast cancer

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Significance Of Multidrug Resistance Gene-Related Proteins In The Postoperative Chemotherapy Of Gastric Cancer

Application of next-generation sequencing in detection of breast cancer susceptibility genes BRCA1/2,TP53 and PTEN germline mutation

Correlation analysis of SLC29A1 gene mutation with gemcitabine toxicity and clinical prognosis in treating advanced pancreatic cancer

A study on the mutation and expression of c-kit and PDGFR-α gene in gastrointestinal stromal tumor

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers

Clinical Significance of Products Related to Multidrug Resistance Gene in Individualized Treatment for Stomach Cancer

Protein Expression and Correlation with Prognosis of Three Drug Resistant Genes in Human Breast Carcinoma

Cmar_a_298729 3303..3316

Prognostic Significance of P-glycoprotein Expression in Mastocarcinoma

Effect of GSTP1 Genetic Polymorphism on Sensitivity of Platinum-Based Chemotherapy